Cancer-related Bone Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2020-11-20
EMA Authorised: Zoledronic acid medac (zoledronic acid monohydrate) — medac Gesellschaft für klinische Spezialpräparate mbH
The EMA authorised zoledronic acid monohydrate (Zoledronic acid medac) for use in fractures/bone-related conditions and cancer, under the ma…